We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo






  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 116

NASDAQ Biotechnology Index surpasses all-time high in 1Q13

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • May 16 2013

The NASDAQ Biotechnology Index reportedly rose in the first quarter of 2013 (1Q13) above levels last seen during the 2000 genomics bubble peakthe

Healthcare & life sciences private equity deal tracker: Argon Medical Devices completes acquisition of Angiotech Pharmaceuticals subsidiary

  • McGuireWoods LLP
  • -
  • Canada, USA
  • -
  • May 8 2013

Argon Medical Devices has completed its acquisition of the interventional products business of Angiotech Pharmaceuticals Inc., according to a news

Healthcare & life sciences private equity deal tracker: dynamic healthcare services acquires APO2

  • McGuireWoods LLP
  • -
  • USA
  • -
  • March 26 2013

Dynamic Healthcare Services Inc. has announced it has acquired APO2. Dynamic Healthcare Services, based in Irvine, Calif., is a provider of home

IMS health acquires appature

  • McGuireWoods LLP
  • -
  • USA
  • -
  • March 20 2013

IMS Health has announced it has acquired Appature. IMS Health, which has its global headquarters in Danbury, Conn., is a provider of healthcare

Supreme Court narrows scope of antitrust immunity in ruling on hospital merger

  • Williams Mullen
  • -
  • USA
  • -
  • February 25 2013

A unanimous U.S. Supreme Court has ruled that the state-action immunity doctrine does not shield an allegedly anticompetitive hospital acquisition

Supreme Court tightens the scope of antitrust immunity in Government-owned hospital mergers

  • Hogan Lovells
  • -
  • USA
  • -
  • February 22 2013

In a unanimous and favorable decision for the Federal Trade Commission (FTC), the Supreme Court found that the state action immunity doctrine does

Supreme Court holds antitrust law applies to state hospital authority transaction

  • Baker & Hostetler LLP
  • -
  • USA
  • -
  • February 21 2013

In one of the most closely watched healthcare antitrust cases in years, the Supreme Court issued its decision in the FTC merger challenge to a

Supreme Court unanimously rules unforeseeability bars immunity defense for allegedly anticompetitive hospital merger

  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • -
  • USA
  • -
  • February 21 2013

On February 19, 2013, the U.S. Supreme Court unanimously held that state-action immunity does not protect a state-created hospital authority from

Private equity investing in the compounding pharmacy sector

  • McGuireWoods LLP
  • -
  • USA
  • -
  • February 10 2013

In light of the integrity and clinical issues raised by the New England Compounding Centers far-reaching recalls in late 2012, the FDA has urged

Biotech investments rise in Q4 2012, but remain off for the year

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • January 24 2013

Pricewatershouse Coopers LLP has released its fourth quarter (Q4) and final 2012 venture capital investment reports and notes that "Biotechnology

Current Search

Suggested Facets

Author

Firm Name

Jurisdiction

Workarea

© Copyright 2006-2013 Globe Business Publishing Ltd | Cookies | Disclaimer | Privacy policy